Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000729922 | SCV000857624 | uncertain significance | not provided | 2017-10-25 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002067102 | SCV002456369 | likely benign | Nephronophthisis | 2025-01-11 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV001700298 | SCV001919754 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000729922 | SCV001964851 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004535830 | SCV004738061 | likely benign | NPHP4-related disorder | 2023-05-04 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |